ABOUT VHIO

VHIO is a leading comprehensive cancer center of excellence where its scientists and physicians adopt a purely translational research model, working together as multidisciplinary teams to both accelerate and advance personalized and targeted therapies against cancer:

DISCOVER MORE

PROGRAMS & GROUPS

Scientific activity at VHIO is structured across for major programs: Preclinical, Translational, Clinical Research, and Core Technologies. Each incorporates research teams of excellence dedicated to harnessing and rapidly translating discoveries into tangible benefits for patients.

MEET VHIO´S TEAMS

NEWS

LEGACy launch: VHIO partners with leading experts across 9 countries to advance precision medicine against gastric cancer

17/01/2019|Comments Off on LEGACy launch: VHIO partners with leading experts across 9 countries to advance precision medicine against gastric cancer

Multicenter Spanish phase II signposts new strategy to treat high-risk localized prostate cancer

15/01/2019|Comments Off on Multicenter Spanish phase II signposts new strategy to treat high-risk localized prostate cancer

World Cancer Day 04 February 2019 “I Am and I will”: what can you do?

10/01/2019|Comments Off on World Cancer Day 04 February 2019 “I Am and I will”: what can you do?

VHIO-born spin-off Peptomyc S.L. jointly awarded Most Innovative Life Sciences Start-up 2018 at leading European partnering event for technology transfer

04/01/2019|Comments Off on VHIO-born spin-off Peptomyc S.L. jointly awarded Most Innovative Life Sciences Start-up 2018 at leading European partnering event for technology transfer

See all news
BROWSE OUR PIs
Launch our Scientific Report 2017

DIRECTION &
PRINCIPAL INVESTIGATORS

Research at VHIO is led by our Director, Josep Tabernero, and supported by a consultative body, VHIO’s Scientific Committee. A total of 26 renowned Principal Investigators manage and run VHIO’s major research themes and programs.

Follow us:

CLINICAL TRIALS

Driving drug development & targeted therapies against cancer, VHIO has become a leading reference in drug discovery from concept to clinic:

CLINICAL TRIALS OFFICE
RESEARCH UNIT FOR MOLECULAR THERAPY OF CANCER – “LA CAIXA”
CURRENTLY OPEN TRIALS

PROJECTS & INSTITUTIONAL PROGRAMS

Research at VHIO is made possible through the support received from private institutions, funding entities, companies and individuals, as well as International and National Competitive Grants. Find out more about our supporters, current projects and VHIO´s Scientific Coordination Area:

CURRENT PROJECTS
BBVA FOUNDATION’s IMMUNOTHERAPY
& IMMUNOLOGY PROGRAM (CAIMI)
OBRA SOCIAL “LA CAIXA”
INTL RESEARCH & EDUCATION PROGRAM
SCIENTIFIC COORDINATION

EVENTS

VHIO organizes symposia of excellence and ad-hoc courses & workshops through which it shares its expertise and promotes debate and exchange of the highest degree:

FEATURED EVENT 2019
INTERNATIONAL SYMPOSIA
WORKSHOPS & COURSES
BENCHSTORMING SEMINARS